<- Go Home
Integrum AB (publ)
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.
Market Cap
SEK 348.2M
Volume
40.3K
Cash and Equivalents
SEK 34.1M
EBITDA
-SEK 14.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 87.7M
Profit Margin
83.88%
52 Week High
SEK 64.00
52 Week Low
SEK 17.20
Dividend
N/A
Price / Book Value
2.04
Price / Earnings
-22.20
Price / Tangible Book Value
2.04
Enterprise Value
SEK 319.7M
Enterprise Value / EBITDA
-24.98
Operating Income
-SEK 16.9M
Return on Equity
9.96%
Return on Assets
-5.99
Cash and Short Term Investments
SEK 34.1M
Debt
SEK 5.6M
Equity
SEK 170.9M
Revenue
SEK 104.5M
Unlevered FCF
-SEK 32.3M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium